Whalegun
Home

Jazz Pharmaceuticals JAZZ paid Tarplin, Downs & Young $80K for lobbying in Q4 2022 · Health Issues

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q4 2022
Stock
Jazz Pharmaceuticals JAZZ
Client
Jazz Pharmaceuticals
Reported
23/01/20

$880K on lobbying in 2022

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Jazz Pharmaceuticals's other lobbying reports

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $80K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $490K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/20

  • Jazz Pharmaceuticals

    LobbyingJazz Pharmaceuticals

    $50K

    Reported 07/19

Jazz Pharmaceuticals JAZZ paid Tarplin, Downs & Young $80K for lobbying in Q4 2022 · Health Issues | Whalegun